Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

211 results about "Uterine endometrium" patented technology

The endometrium is the lining that is inside the uterus. It prevents the middle layer of the uterus, called the myometrium, from developing adhesions, and provides an area for the placenta to attach to the uterus during pregnancy.

Construction method of uterine stromal cell specific gene editing mouse

ActiveCN119120466ASolving complex breeding problemsOvercoming the challenge of difficult knockoutHydrolasesMicroinjection basedIntracellularStromal cell
The invention belongs to a molecular biological technology, discloses a construction method of a uterus stromal specific gene editing mouse, and relates to a CRISPR-Cas9-based stromal specific gene editing mouse. The Cre mouse using Vim as a specific promoter activates Cas9, and the Cas9 mouse not only solves the problem of complex breeding of the traditional Cre mouse, but also can realize tissue specific knockout without homozygosis. Cas9 mice can be used for knocking out various sgRNAs, and more possibilities are provided for development of a gene editing model. The obtained Cas9 mouse is mated with an sgMettl3 report mouse, and the Mettl3 gene is successfully knocked out in the uterine stromal cells in a guided manner. The invention provides a valuable gene editing model for endometrial gene research, and overcomes the challenge of difficult knockout of bispecific site mediated genes.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Application of mesenchymal stem cells in medicine for treating thin endometrial and intrauterine adhesion

The invention discloses an application of mesenchymal stem cells in a medicine for treating thin endometrium and intrauterine adhesion, and relates to the technical field of treatment of endometrium-related diseases, the medicine comprises umbilical cord mesenchymal stem cells, amniotic decellularized scaffolds and polyglycerol sebacate; through construction of thin endometrium and intrauterine adhesion models, it is found that by means of the medicine, the thickness of endometrium, the number of glands and the endometrial fibrosis level of a rat can be effectively improved, release of inflammatory factors of the intrauterine adhesion rat model can be effectively reduced, proliferation of fibroblasts is inhibited, inflammatory response is relieved, and the effect of treating the intrauterine adhesion is achieved. And the effects of resisting endometrial fibrosis and promoting endometrial repair are achieved, so that the aims of improving and treating thin endometrial diseases and intrauterine adhesion are fulfilled.
Owner:REIN CELL ENG TECH (GUANGZHOU) CO LTD

Method and system for enhanced visualization of fibroids with respect to a uterus and endometrium in ultrasound imaging

Systems and methods for enhancing visualization and documentation of fibroid quantity, size, and location with respect to a uterus and endometrium in ultrasound imaging are provided. The method includes receiving, by at least one processor, an ultrasound volume including ultrasound image data of a region of interest that includes a uterus. The method includes automatically segmenting, by the at least one processor, the uterus and an endometrium in the ultrasound volume. The method includes segmenting one or more fibroids in the ultrasound image data. The method includes generating a classification of each of the one or more fibroids based on a location of each of the one or more fibroids with respect to the endometrium and the uterus. The method includes causing, by the at least one processor, a display system to present at least one image identifying the segmented uterus, endometrium, and one or more fibroids.
Owner:GE PRECISION HEALTHCARE LLC

Method for preparing endometrial organoid and uses thereof for treating uterine fibrosis and ameliorating aging

PCT designated stage expiredWO2025127812A1Culture processArtificial cell constructsCollagen accumulationAshermann syndrome
A pharmaceutical composition according to an aspect can be applied to the prevention, treatment or the like of endometrial damage, Asherman's syndrome, or complications thereof by: reducing the level of collagen accumulation in the endometrium; increasing the expression level of VEGF; increasing the expression level of Ki67; increasing the expression level of Itgb3; increasing the expression level of Spp1; increasing the number of implantation sites; decreasing the expression levels of fibrosis-related factors; decreasing the expression levels of metabolism-related factors; increasing ATP production; and regulating the expression levels of mitochondrial function-related factors.
Owner:COLLEGE OF MEDICINE POCHON CHA UNIV IND ACADEMIC COOP FOUND

Self-healing hydrogel for preventing intrauterine adhesion as well as preparation method and application of self-healing hydrogel

The invention relates to self-healing hydrogel for preventing intrauterine adhesion and a preparation method and application thereof. The preparation method comprises the following steps: dissolving hyaluronic acid in ultrapure water, then adding EDC and NHS, adjusting the pH value, then adding cysteamine hydrochloride, and after the reaction is finished, dialyzing and freeze-drying to obtain sulfydryl modified hyaluronic acid marked as HASH; dissolving the HASH in ultrapure water, then adding EDC and NHS, adjusting the pH value, then adding dopamine hydrochloride, and after the reaction is finished, dialyzing and freeze-drying to obtain sulfydryl and dopamine modified hyaluronic acid which is marked as DAHASH; carrying out surface sulfhydrylation treatment on the mEXO to obtain an engineered exosome which is marked as SmEXO; and respectively dissolving the DAHASH, the SmEXO and silver nitrate in ultrapure water, and then mixing to obtain an exosome-hydrogel system which is marked as DAHASH (at) SmEXO. The hydrogel for preventing intrauterine adhesion has a self-healing characteristic, is suitable for a special structure of an intrauterine, can be anchored on a wounded surface of a uterus, is continuously adhered to an endometrium for slowly releasing SmEXO, and creates a good condition for long-term repair of the endometrium.
Owner:ANHUI PROVINCIAL HOSPITAL

Medical scraping and sucking forceps head with transparent anti-sticking silicon coating

The utility model discloses a medical scraping and sucking forceps head with a transparent anti-sticking silicon coating, which comprises scraping forceps, the scraping forceps comprise forceps heads and handles, the forceps heads are fixedly arranged at one ends of the forceps heads, and the number of the handles and the number of the forceps heads are both two. When the suction tube is used for sucking the endometrium or uterine cavity contents, residues can be adhered to the inner wall of the suction tube and are difficult to completely remove when suction force is insufficient, after uterine curettage is finished, the whole device is taken out, the motor is started, the motor drives the lead screw to rotate, the lead screw is driven by the motor to rotate, and the endometrium or uterine cavity contents are sucked away through the suction tube. The lead screw drives the movable ring in threaded connection to move, the movable ring and the cleaning ring are fixedly connected through the connecting piece and the like, when the movable ring slides on the suction pipe, the cleaning ring slides in the suction pipe, residues attached to the inner wall of the suction pipe are cleaned, and the residues can be sucked away by the suction device conveniently.
Owner:BILL-ANDA (ANHUI) NANO COATING TECH CO LTD

Uterine cavity sampler

ActiveCN222055461UEnsure complete samplingSurgical needlesTunica intimaMechanical engineering
The utility model discloses a uterine cavity sampler, which belongs to the technical field of medical treatment, and comprises a sampling component, the sampling component is provided with a support part for entering the uterus and a sampling tube connected to the surface of the support part, and the inlet of the sampling tube is connected with a scraping part. The scraping part is used for scraping and sampling an endometrial sample when the sampling tube is in a rotating state; the sampling component is connected with the operating rod so as to adjust the position and / or posture of the sampling component in the uterus. According to the technical scheme, the sampling component is fed into the uterus through the operating rod, and then the operating rod is controlled to drive the sampling component to rotate. When the sampling tube on the sampling component rotates, the scraping part rotates along with the sampling tube and scrapes the circumference of the uterine wall in the rotating process, so that an endometrial sample on the uterine wall is relatively completely scraped down, and the complete sampling is ensured.
Owner:ANHUI PROVINCIAL HOSPITAL

Functional polypeptide for promoting repair of endometrial stem cells to clitoris sensitive nerves and application

The invention discloses a functional polypeptide for promoting repair of endometrial stem cells to clitoris sensitive nerves and application, and belongs to the technical field of stem cell repair, the functional polypeptide is used for modifying the endometrial stem cells and Schwann cells through the functional polypeptide, and the clitoris sensitive nerves are repaired in a local slow-release gel delivery mode. The functional polypeptide can activate Laminin expression and regulate and control ECM degradation balance, so that collagen deposition in scar tissues is reduced; in addition, the functional polypeptide can effectively inhibit HOXA1 expression, enhance the axon extension capacity and strengthen the axon microtubulin polymerization capacity of the nerve injury part, and the nerve repair efficiency and the function recovery quality are remarkably improved.
Owner:广东圆康再生医学科技开发有限公司

Slow-release gel preparation for endometrial repair and preparation method thereof

The invention relates to the technical field of medical gel, and particularly discloses a sustained-release gel preparation for endometrial repair and a preparation method of the sustained-release gel preparation. Keratinocyte factor sustained-release microspheres containing keratinocyte factor-glucan particles and lactic acid-glycolic acid copolymer shells are constructed around keratinocyte factors, and the keratinocyte factor sustained-release microspheres are loaded by hyaluronic acid hydrogel containing polylysine, collagen and silk fibroin to form the sustained-release gel preparation for endometrial repair. The sustained-release gel preparation has the effect of promoting proliferation of human endometrial cells, can repair endometrial injury, promote injury healing and prevent uterine cavity adhesion, and has important significance in treating endometrial injury and improving physical and psychological health of women.
Owner:SHAANXI ZHONGKE TONGDA LIFE SCI TECH CO LTD

Method and system for predicting onset risk of endometrial disease

The invention relates to the technical field of diagnosis of gynecological and obstetrical diseases, in particular to an endometrial disease onset risk prediction method and system. By combining multiple groups of indexes and image group feature data, the endometrium can be effectively evaluated, score data reflecting the tumor state of the endometrial disease can be obtained, and the incidence probability and the staging result degree of the endometrial disease can be more intuitively determined through the score data. Therefore, the overall automatic prediction of the endometrial disease is realized.
Owner:SUINING CENT HOSPITAL

Systems and methods for endometrial ablation

A system for treating uterine tissue having a seal assembly configured for positioning in a patient's cervical canal and uterine cavity; an expandable distal balloon portion; an expandable elongate medial balloon portion configured for movement between a first transversely expanded shape for engaging a cervical canal and a second transversely non-expanded shape for trans-cervical insertion; and a fluid source in communication with distal balloon portion and medial balloon portion for expansion of said balloon portions.
Owner:AXORA MEDICAL INC

Construction method and application of polycystic ovarian syndrome endometrial epithelium organ fibrosis model

The invention relates to the technical field of biology, and particularly discloses a construction method and application of an endometrial epithelium organ fibrosis model. According to the method, human endometrial epithelial cells are extracted, and an endometrial epithelial organ is established by adopting a Matrigel three-dimensional culture system. Afterwards, the organoid is induced to form endometrial phenotypes in different physiological cycles through hormone stimulation, and a ferroptosis inducer FIN56 is added in the culture process to induce fibrosis. The expression of GPX4, Fibronectin and p-Smad2 / 3 is detected through Western blot and immunofluorescence, and the successful construction of the fibrosis model is verified. The invention provides an in-vitro model capable of simulating endometrial fibrosis pathological characteristics of a patient with PCOS (polycystic ovarian syndrome), the in-vitro model can be used for mechanism research and drug screening of PCOS-related endometrial lesions, and a new research tool and an intervention strategy are provided for treatment of PCOS endometrial fibrosis.
Owner:PEKING UNIVERSITY THIRD HOSPITAL (THE THIRD CLINICAL MEDICAL SCHOOL OF PEKING UNIVERSITY)

Degradable shape memory isolating membrane in uterine cavity and preparation method thereof

The invention relates to the technical field of biological materials, in particular to an intrauterine degradable shape memory isolating membrane and a preparation method thereof. The raw materials of the isolating membrane at least comprise a compound of an artificial high-molecular compound and a natural high-molecular compound. The mass ratio of the artificial high-molecular compound to the natural high-molecular compound is (5-95): (95-5); the isolating membrane is used for loading the medicine and continuously releasing the medicine into the uterine cavity. The isolating membrane is folded and conveyed to a womb wound part after an operation, the purpose of automatically unfolding the isolating membrane to reach the womb wound part is achieved, and intrauterine adhesion is physically blocked. In addition, the isolating membrane can load bioactive medicines according to requirements, so that the functions of relieving pain or stimulating and continuously activating an endometrial basal layer are realized, the occurrence of uterine scars is inhibited, and the normal uterine fertility function of a patient can be recovered more quickly.
Owner:SHANGHAI RUINING BIOTECH CO LTD

Uterine endometrial fluid for prediction of success in fertility treatment

To provide methods, systems, and kits for improving success rates in assisted reproductive technologies such as in vitro fertilization, frozen embryo transfer, and intrauterine insemination.SOLUTION: Provided is a method of predicting negative pregnancy outcome in fertility treatment, the method comprising: (a) contacting uterine endometrial secretions from a patient with a kit containing a solid-state substrate functionalized to identify at least two markers associated with a hostile endometrial environment selected from the group consisting of proteins, metabolites, or miRNAs; and (b) determining a secretome profile of the uterine endometrial secretions to ascertain an increase or decrease in the presence of markers associated with the hostile endometrial environment. An increase or decrease in the presence of the one or more markers associated with the hostile endometrial environment, compared to the secretome profile of uterine endometrial secretions of a successful pregnancy outcome, predicts negative pregnancy outcome.SELECTED DRAWING: None
Owner:FERTILITY LAB SCIENCES LLC

Method and system for enhancing visualization of myoma relative to uterus and endometrium in ultrasound imaging

Methods for enhancing the visualization of a myoma relative to the uterus and endometrium in ultrasound imaging are provided. The method includes receiving, by at least one processor, an ultrasound volume including ultrasound image data of a region of interest, automatically segmenting the uterus and endometrium in the ultrasound volume, segmenting one or more myomas in the ultrasound image data, and outputting the one or more myomas. A classification of each of the one or more myomas is generated based on a position of each of the one or more myomas relative to the endometrium and the uterus such that the display system presents at least one image identifying the segmented uterus, endometrium, and one or more myomas. The application also provides a system for enhancing the visualization of a myoma relative to the uterus and endometrium during ultrasound imaging.
Owner:GE PRECISION HEALTHCARE LLC

Lightweight yolov8-based endometrial inflammation classification and identification method and system

The invention relates to a lightweight yolov8-based endometritis classification and identification method and system, and the method comprises the steps: determining classified target historical hysteroscope image data, and enabling classification labels to comprise a normal classification group indicating normal endometrium and a lesion classification group indicating the existence of endometritis; dividing the target historical hysteroscope image data according to a preset distribution proportion to obtain training data and verification data; training data and verification data are input into a yolov8 classification model, in the training process, model lightweight processing is carried out based on weight importance pruning, quantification and knowledge distillation technologies, and feature weighting and selection based on an attention mechanism are carried out on target area features detected by yolov8 and related to endometrium and pre-acquired auxiliary modal features, so that the model weight is reduced; key feature information is extracted; and inputting real-time hysteroscope image data into the trained yov8 classification model to obtain an endometrial inflammation classification result for auxiliary diagnosis.
Owner:TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH

Pharmaceutical composition for treating uterine cavity adhesion and application thereof

The invention relates to a pharmaceutical composition for treating uterine adhesion and application thereof. The kidney reinforcing and miscarriage preventing pills are used for improving endometrial blood perfusion and increasing the endometrial thickness, the kidney reinforcing and miscarriage preventing pills, aspirin and estrogen play a synergistic treatment role, the postoperative re-adhesion rate is remarkably reduced through combined treatment, and the fertility prognosis of a patient is improved; and the molecular mechanism of a TGF-beta1 pathway and EMT is deeply researched, and by inhibiting excessive activation of the TGF-beta1 signaling pathway, reducing endometrial fibrosis, regulating an epithelial-mesenchymal transition (EMT) process and promoting regeneration of endometrial epithelial cells, endometrial repair is further promoted, multi-target treatment is realized, and the treatment effect is remarkable. A brand-new and efficient treatment scheme is provided for treatment of intrauterine adhesion, an individualized treatment scheme can be formulated according to the specific conditions of patients, the treatment accuracy and effectiveness are improved, and important clinical significance and application value are achieved.
Owner:BEIJING HAORUIYUAN BIOTECHNOLOGY CO LTD

Mouse model construction method for severe endometrial injury ineffective in MSCs treatment

The invention belongs to the technical field of medical model construction, and particularly relates to a construction method of a severe endometrial injury mouse model ineffective in MSCs treatment. The method specifically comprises the following steps: S1, selecting a female mouse to adapt to the environment for 2-3 days; s2, after the mouse adapts to the environment, anesthetizing the mouse on the 0th day, performing laparotomy to physically scrape the inner uterine wall of the mouse, and then performing injury induction and suturing on the inner uterine wall by using an LPS (Lipopolysaccharide) solution; s3, repeating the step S2 on the third day, and performing laparotomy, curettage, LPS induction and suture on the mouse; s4, preliminarily evaluating the severe endometrial injury condition of the mouse on the fifth day; s5, injecting MSCs into the uterus of the mouse with the severe endometrial injury to treat the endometrial injury; and S6, on the eighth day, collecting a uterus sample to evaluate the repair capability of the MSCs, and screening to obtain the severe endometrial injury mouse model ineffective in MSCs treatment. Through a mode of carrying out physical curettage and lipopolysaccharide induction on the uterus through twice laparotomy, severe IUA patients ineffective in clinical MSCs treatment are better simulated.
Owner:CHINA PHARM UNIV

Drug release instrument and endoscope assembly

The invention discloses a medicine release instrument and an endoscope assembly, and relates to the technical field of endoscopes. The drug release instrument comprises a first tube body, a balloon and a light-emitting structure. The balloon is arranged to be of a light-transmitting and expandable structure, the inner cavity is defined by the structural layer of the balloon, the inner cavity and the far end of the first tube body are arranged in a sealed mode and communicate with each other, meanwhile, the first tube body extends into the inner cavity, and then the light-emitting structure is arranged in the balloon; light emitted by the light-emitting structure and the photosensitive cross-linked medicine composite layer located outside the structural layer are utilized to induce a cross-linking reaction, after the balloon stretches into the uterus, liquid can be injected into the balloon through the first tube body so that the balloon can be expanded, the balloon can abut against the endometrium after being expanded, and after the light-emitting structure emits the light, the light-emitting structure can emit the light. The photosensitive cross-linked drug composite layer can be adhered to the surface of the endometrium, so that the drug in the photosensitive cross-linked drug composite layer can be fully and tightly adhered to the endometrium, and the endometrium can be continuously treated or repaired.
Owner:HUNAN HUAXIN MEDICAL TECHNOLOGY CO LTD

Traditional Chinese medicine prescription efficacy evaluation system for treating intrauterine adhesion

The invention relates to the technical field of medical care information processing, and discloses a traditional Chinese medicine prescription efficacy evaluation system for treating intrauterine adhesion, comprising: a data preprocessing module for acquiring endometrial dynamic response gray time sequence characteristic data before and after a subject takes a prescription; the phase analysis module is used for determining a phase deviation distribution coefficient according to the phase angle distribution of the gray scale data of the reference pixel and the response pixel; the frequency domain inversion module is used for constructing an energy transfer gain spectrum by calculating a power ratio and identifying a characteristic resonant frequency; the evaluation index output module is used for generating an evaluation index for evaluating the viscoelasticity improvement degree of the endometrial tissue according to the deviation value of the characteristic resonant frequency in combination with the variation of the phase deviation distribution coefficient. And the quantitative accuracy of evaluation is improved.
Owner:PEOPLES HOSPITAL AFFILIATED TO FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE (FUJIAN PROVINCIAL PEOPLES HOSPITAL)

A peristaltic wave parameter measurement method and ultrasonic measurement system

A peristaltic wave parameter measurement method and ultrasonic measurement system, the method comprising: transmitting a first ultrasonic wave to the endometrium of a measured object, receiving an ultrasonic echo returned by the endometrium, to obtain a first ultrasonic echo signal; processing the first ultrasonic echo signal to obtain a peristaltic parameter in a target area of ​​the endometrium that changes with time; obtaining a transmission time of the peristaltic wave in the target area based on the peristaltic parameter in the target area that changes with time; and outputting the transmission time. The peristaltic wave parameter measurement method and ultrasonic measurement system quantify and output the transmission time of the peristaltic wave as a new peristaltic wave-related parameter, providing users with an objective measurement tool for peristaltic waves.
Owner:ZHEJIANG PROVINCIAL PEOPLES HOSPITAL +1

Intelligent monitoring method and system for perfusion curative effect of thin endometrial rich microplate

The invention relates to the technical field of medical artificial intelligence monitoring, and discloses an intelligent monitoring method and system for a perfusion curative effect of a thin endometrial rich microplate. The method comprises the following steps: standardizing and fusing multi-source monitoring data, constructing a derivative feature set reflecting a treatment coordination rule through cross-cycle feature derivation, and establishing a curative effect behavior coding library according to the derivative feature set. After the real-time data is subjected to standardization processing, frame-by-frame mode matching and similarity calculation are carried out on the real-time data and a coding library, a corresponding analysis path is activated according to a result, and a curative effect behavior fragment with a timestamp is generated. The segments are associated and aggregated to form a complete curative effect event chain, key turning points are marked, and finally a structured monitoring report and a decision signal are generated through multi-dimensional influence evaluation. According to the invention, the conversion from static parameter judgment to dynamic curative effect behavior intelligent analysis is realized, and the continuity, accuracy and early warning capability of treatment process monitoring are improved.
Owner:NINGER HOSPITAL CO LTD

Ultrasonic imaging method and device

An ultrasonic imaging method and device and a computer-readable storage medium are provided. The ultrasonic imaging method includes: ultrasonic waves are transmitted to a uterine region of an object to be detected; ultrasonic echoes are received based on the ultrasonic waves reflected from the uterine region of said object, and ultrasonic echo signals are acquired on the basis of the ultrasonic echoes; the ultrasonic echo signals are processed to obtain three-dimensional data of the uterine region of said object; the endometrium is identified from the three-dimensional data of the uterine region according to endometrium image characteristics of the uterine region to obtain position information of the identified endometrium; according to the position information of the identified endometrium, the cross section of the identified endometrium is imaged on the basis of the three-dimensional data to obtain an cross-sectional endometrium image; and the cross-sectional endometrium image is displayed.
Owner:SHENZHEN MINDRAY BIO MEDICAL ELECTRONICS CO LTD

Use of ethinylestradiol and drospirenone for the preparation of a medicament for the treatment of post-traumatic stress disorder

PendingCN122351259ADrospirenoneOral contraceptive drug
This invention discloses the application of ethinylestradiol and drospirenone in the preparation of drugs for treating post-traumatic stress disorder (PTSD). Ethinylestradiol, as an estrogen receptor agonist, regulates the hypothalamic-pituitary-gonadal axis and is used to treat female hypogonadism, menopausal syndrome, and advanced breast cancer, often in combination with progestins as oral contraceptives. The use of drospirenone and ethinylestradiol tablets (II) after induced abortion can shorten vaginal bleeding time, promote endometrial repair, and reduce the incidence of postoperative complications and repeat miscarriages. This invention has found that ethinylestradiol and drospirenone can reverse the abnormal decrease in hormones and neurosteroids caused by PTSD after spontaneous abortion, particularly the abnormal decrease in serotonin and tetrahydroprogesterone.
Owner:WOMEN S HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE

Artificial insemination and endometrium sampling device with visual uterine cavity

The invention relates to the field of human body sampling devices, and particularly discloses an artificial insemination and endometrium sampling device with a visual uterine cavity. The main pipeline and the auxiliary pipeline are arranged on the mounting head, the push-pull rod and the piston are arranged in the main pipeline, and the lens tube of the endoscope is inserted into the auxiliary pipeline through the inner curve of the mounting head, so that when the endometrium of a patient is finely sampled, a shot picture of the lens tube can be obtained through the endoscope; the main pipeline and the auxiliary pipeline are stretched into appropriate positions in the uterus according to images, then endometrium sampling operation is completed, when artificial insemination operation is carried out, images can be shot through a lens tube of an endoscope, the main pipeline and the auxiliary pipeline are stretched into appropriate positions in the vagina, and then the artificial insemination operation is completed. Endometrial sampling operation and artificial insemination operation are visually completed, and the efficiency of medical work can be effectively improved.
Owner:刘晓宁

Functionalized lipid nanoparticles for targeted delivery to endometrium

LNPs can penetrate uterine mucosa to deliver therapeutic or prophylactic agents such as functional nucleic acids to the endometrium. Targeting of the LNPs using ligands expressed at particular times in an endometrial cycle ensures that the LNPs penetrate and release the mRNA primarily to the tissue associated with the peak time period for implantation, thereby providing a means to address infertility, as well as for treatment of other disorders such as cancer.
Owner:JOHNS HOPKINS UNIVERSITY

Woman uterus disease auxiliary diagnosis and evaluation system based on magnetic resonance imaging

PendingCN121506459AImage enhancementImage analysisUterine diseasePosition uterus
The invention relates to the technical field of uterus image segmentation, in particular to a woman uterus disease auxiliary diagnosis and evaluation system based on magnetic resonance imaging. After a uterus image of a patient is obtained and a uterine cavity area is positioned, clustering clusters are divided according to pixel gray values by using a clustering algorithm to correspond to different uterus areas. And generating an endometrial region descriptor and screening out an endometrial region by combining the pixel number distribution of each region, the gray features and the shape difference between the endometrial region descriptor and the uterine cavity. Performing gray scale segmentation on the region to extract a high-signal region, and calculating an internal descriptor according to internal edge distribution and morphological characteristics of the high-signal region; meanwhile, an external descriptor is generated based on edge pixel neighborhood gray scale difference. And finally fusing internal and external descriptors to realize auxiliary diagnosis of uterine diseases. According to the method, the uterus image with obvious uterine cancer staging development tendency can be screened out, and a more accurate diagnosis effect is provided for related personnel.
Owner:SHANGLUO CENT HOSPITAL

Endometrial stem cell preparation for cervical hypertrophy and repair of villi

This invention discloses an endometrial stem cell preparation and its application for cervical hypertrophy and cuticle repair, belonging to the field of stem cell technology. The endometrial stem cell preparation includes a stem cell gel carrier, endometrial stem cells, auxiliary repair peptides, and a survival enhancer. In the endometrial stem cell preparation, the stem cell gel carrier, endometrial stem cells, auxiliary repair peptides, and survival enhancer work synergistically to improve the survival rate of endometrial stem cells in vivo. The auxiliary repair peptides can activate the MAPK / ERK pathway of endometrial stem cells, and the anti-inflammatory mimic peptides in the survival enhancer can inhibit the stress silencing of endometrial stem cells, thereby ensuring the secretory function of endometrial stem cells. Furthermore, the three-dimensional porous structure of the stem cell gel carrier enhances the targeted repair ability of endometrial stem cells and enhances the homing and colonization of endometrial stem cells to cervical lesions.
Owner:广东圆康再生医学科技开发有限公司

Uterine cavity treatment device

The invention provides a uterine cavity treatment device, and belongs to the technical field of uterine cavity postoperative continuous treatment devices. The treatment device comprises a uterine cavity support and a conveying system, the uterine cavity support comprises a supporting framework and a medicine carrying covering film, a main body of the supporting framework is of a big-end-up three-dimensional cage-shaped structure, angle-shaped protrusions are symmetrically arranged on the left side and the right side of the far end of the supporting framework, and the angle-shaped protrusions obliquely extend upwards with the center of the uterine cavity support as the reference; an arc-shaped structure is formed, so that the whole shape of the supporting skeleton is matched with the uterus shape after the supporting skeleton is automatically expanded; the medicine carrying covering film is at least arranged on the outer side of the supporting framework; a hormone sustained-release drug is arranged in the drug-loading covering membrane and is used for promoting repair of endometrium; the conveying system is used for loading the uterine cavity stent in a contracted state and conveying the uterine cavity stent to a target position to complete release; the technical problem that in the prior art, the effect of treating intrauterine adhesion after an intrauterine operation is poor is mainly solved.
Owner:修原(辽宁)生物有限公司

An organ-chip-based simulated model of the maternal-fetal interface in systemic lupus erythematosus and a construction method thereof

The application provides a trophoblast organ-on-chip system for simulating a maternal-fetal interface of a systemic lupus erythematosus model based on an organ chip and a construction method thereof, the system taking an organ chip as a carrier and comprising three core parts of a trophoblast organ, an endometrial chip and an SLE disease model. The application completes separation culture and characterization of the trophoblast organ, multi-cell co-culture construction and characterization of the endometrial chip, and then constructs a pathological model, and the three parts cooperatively form a three-dimensional maternal-fetal interface. The system can clearly observe the dynamic process of the trophoblast organ invading the endometrial chip, can detect the continuous secretion of hCG and SLE-related inflammatory factors, and breaks through the defects of the prior art model, such as low authenticity, inability to dynamically observe, single detection dimension and lack of standardization, and has both physiological and pathological adhesion and experimental repeatability, can multi-dimensionally characterize the cell phenotype and function of the maternal-fetal interface, and provides an in-vitro research platform for the pathological mechanism research of the SLE pregnancy-related abnormal maternal-fetal interface.
Owner:AFFILIATED HOSPITAL OF NANTONG UNIV